chr3-52353165-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_015512.5(DNAH1):​c.3090G>A​(p.Ala1030Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00607 in 1,614,012 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1030A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0043 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0063 ( 72 hom. )

Consequence

DNAH1
NM_015512.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.00900

Publications

5 publications found
Variant links:
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
  • spermatogenic failure 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ciliary dyskinesia, primary, 37
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 3-52353165-G-A is Benign according to our data. Variant chr3-52353165-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.009 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00435 (662/152344) while in subpopulation SAS AF = 0.0232 (112/4830). AF 95% confidence interval is 0.0197. There are 5 homozygotes in GnomAd4. There are 337 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH1NM_015512.5 linkc.3090G>A p.Ala1030Ala synonymous_variant Exon 19 of 78 ENST00000420323.7 NP_056327.4 Q9P2D7-4A0A140VJI6
DNAH1XM_017006129.2 linkc.3090G>A p.Ala1030Ala synonymous_variant Exon 20 of 80 XP_016861618.1
DNAH1XM_017006130.2 linkc.3090G>A p.Ala1030Ala synonymous_variant Exon 20 of 79 XP_016861619.1 Q9P2D7-4A0A140VJI6
DNAH1XM_017006131.2 linkc.3090G>A p.Ala1030Ala synonymous_variant Exon 20 of 79 XP_016861620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH1ENST00000420323.7 linkc.3090G>A p.Ala1030Ala synonymous_variant Exon 19 of 78 1 NM_015512.5 ENSP00000401514.2 Q9P2D7-4
DNAH1ENST00000486752.5 linkn.3351G>A non_coding_transcript_exon_variant Exon 19 of 77 2
DNAH1ENST00000497875.1 linkn.3255G>A non_coding_transcript_exon_variant Exon 20 of 21 2

Frequencies

GnomAD3 genomes
AF:
0.00436
AC:
663
AN:
152226
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0123
Gnomad SAS
AF:
0.0234
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00476
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00648
AC:
1615
AN:
249082
AF XY:
0.00750
show subpopulations
Gnomad AFR exome
AF:
0.00174
Gnomad AMR exome
AF:
0.00325
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.0124
Gnomad FIN exome
AF:
0.00158
Gnomad NFE exome
AF:
0.00422
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.00626
AC:
9143
AN:
1461668
Hom.:
72
Cov.:
31
AF XY:
0.00677
AC XY:
4923
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.00176
AC:
59
AN:
33480
American (AMR)
AF:
0.00300
AC:
134
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00168
AC:
44
AN:
26136
East Asian (EAS)
AF:
0.0175
AC:
694
AN:
39700
South Asian (SAS)
AF:
0.0233
AC:
2007
AN:
86256
European-Finnish (FIN)
AF:
0.00152
AC:
81
AN:
53368
Middle Eastern (MID)
AF:
0.00537
AC:
31
AN:
5768
European-Non Finnish (NFE)
AF:
0.00512
AC:
5695
AN:
1111864
Other (OTH)
AF:
0.00659
AC:
398
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
542
1084
1625
2167
2709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00435
AC:
662
AN:
152344
Hom.:
5
Cov.:
33
AF XY:
0.00452
AC XY:
337
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00190
AC:
79
AN:
41574
American (AMR)
AF:
0.00340
AC:
52
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.0123
AC:
64
AN:
5184
South Asian (SAS)
AF:
0.0232
AC:
112
AN:
4830
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00475
AC:
323
AN:
68032
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
41
82
122
163
204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00382
Hom.:
2
Bravo
AF:
0.00374
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.00403
EpiControl
AF:
0.00510

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 28, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
14
DANN
Benign
0.65
PhyloP100
0.0090
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140275399; hg19: chr3-52387181; COSMIC: COSV101325241; API